Hypoxia-inducible Factor Prolyl Hydroxylases As Targets for Neuroprotection by "antioxidant" Metal Chelators: From Ferroptosis to Stroke

Overview

Journal Free Radic Biol Med

Specialties Biochemistry
Biology
General Medicine

Date 2013 Feb 5

PMID 23376032

Citations 71

Authors

Rachel E Speer

Saravanan S Karuppagounder

Manuela Basso

Sama F Sleiman

Amit Kumar

David Brand

Natalya Smirnova

Irina Gazaryan

Soah J Khim

Rajiv R Ratan

Affiliations

Soon will be listed here.

Abstract

Neurologic conditions including stroke, Alzheimer disease, Parkinson disease, and Huntington disease are leading causes of death and long-term disability in the United States, and efforts to develop novel therapeutics for these conditions have historically had poor success in translating from bench to bedside. Hypoxia-inducible factor (HIF)-1α mediates a broad, evolutionarily conserved, endogenous adaptive program to hypoxia, and manipulation of components of the HIF pathway is neuroprotective in a number of human neurological diseases and experimental models. In this review, we discuss molecular components of one aspect of hypoxic adaptation in detail and provide perspective on which targets within this pathway seem to be ripest for preventing and repairing neurodegeneration. Further, we highlight the role of HIF prolyl hydroxylases as emerging targets for the salutary effects of metal chelators on ferroptosis in vitro as well in animal models of neurological diseases.

Citing Articles

Prevents Ferroptosis by Activating the NRF2 Signaling Pathway in a High-Altitude Cerebral Edema Rat Model.

Han Y, Li W, Duan H, Jia N, Liu J, Zhang H Int J Mol Sci. 2025; 26(3).

PMID: 39940878 PMC: 11817441. DOI: 10.3390/ijms26031110.

Mechanistic insights into gut microbe derived siderophores and PHD2 interactions with implications for HIF-1α stabilization.

Patel J, Poyya J, Padakannaya A, Kurdekar N, Khandagale A, Joshi C Sci Rep. 2025; 15(1):1113.

PMID: 39774022 PMC: 11707245. DOI: 10.1038/s41598-024-83730-8.

Tetramethylpyrazine inhibits ferroptosis in spinal cord injury by regulating iron metabolism through the NRF2/ARE pathway.

Tao J, Zhou J, Zhu H, Xu L, Yang J, Mu X Front Pharmacol. 2024; 15:1503064.

PMID: 39619616 PMC: 11605085. DOI: 10.3389/fphar.2024.1503064.

Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.

Feng Y, Shi M, Zhang Y, Li X, Yan L, Xu J Cell Biol Toxicol. 2024; 40(1):104.

PMID: 39589556 PMC: 11599353. DOI: 10.1007/s10565-024-09953-7.

Randomized controlled trial of intermittent hypoxia in Parkinson's disease: study rationale and protocol.

Janssen Daalen J, Meinders M, Mathur S, van Hees H, Ainslie P, Thijssen D BMC Neurol. 2024; 24(1):212.

PMID: 38909201 PMC: 11193237. DOI: 10.1186/s12883-024-03702-3.

References

Carrero P, Okamoto K, Coumailleau P, OBrien S, Tanaka H, Poellinger L . Redox-regulated recruitment of the transcriptional coactivators CREB-binding protein and SRC-1 to hypoxia-inducible factor 1alpha. Mol Cell Biol. 1999; 20(1):402-15. PMC: 85095. DOI: 10.1128/MCB.20.1.402-415.2000. View

Emerling B, Platanias L, Black E, Nebreda A, Davis R, Chandel N . Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol. 2005; 25(12):4853-62. PMC: 1140591. DOI: 10.1128/MCB.25.12.4853-4862.2005. View

Chu P, Beart P, Jones N . Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes. Eur J Pharmacol. 2010; 633(1-3):24-32. DOI: 10.1016/j.ejphar.2010.02.008. View

Wang G, Semenza G . Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem. 1993; 268(29):21513-8. View

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

Wu Y, Li X, Xie W, Jankovic J, Le W, Pan T . Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1 alpha and induction of autophagy in SH-SY5Y cells. Neurochem Int. 2010; 57(3):198-205. DOI: 10.1016/j.neuint.2010.05.008. View

Hanson L, Roeytenberg A, Martinez P, Coppes V, Sweet D, Rao R . Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther. 2009; 330(3):679-86. PMC: 2729791. DOI: 10.1124/jpet.108.149807. View

Goldman S, Chen E, Taylor R, Zhang S, Petrosky W, Reiss M . Use of the ODD-luciferase transgene for the non-invasive imaging of spontaneous tumors in mice. PLoS One. 2011; 6(3):e18269. PMC: 3066234. DOI: 10.1371/journal.pone.0018269. View

Freret T, Valable S, Chazalviel L, Saulnier R, MacKenzie E, Petit E . Delayed administration of deferoxamine reduces brain damage and promotes functional recovery after transient focal cerebral ischemia in the rat. Eur J Neurosci. 2006; 23(7):1757-65. DOI: 10.1111/j.1460-9568.2006.04699.x. View

10.

Ravi R, Mookerjee B, Bhujwalla Z, Sutter C, Artemov D, Zeng Q . Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000; 14(1):34-44. PMC: 316350. View

11.

Ratan R, Siddiq A, Aminova L, Lange P, Langley B, Ayoub I . Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke. 2004; 35(11 Suppl 1):2687-9. DOI: 10.1161/01.STR.0000143216.85349.9e. View

12.

Koh M, Powis G . Passing the baton: the HIF switch. Trends Biochem Sci. 2012; 37(9):364-72. PMC: 3433036. DOI: 10.1016/j.tibs.2012.06.004. View

13.

Marxsen J, Stengel P, Doege K, Heikkinen P, Jokilehto T, Wagner T . Hypoxia-inducible factor-1 (HIF-1) promotes its degradation by induction of HIF-alpha-prolyl-4-hydroxylases. Biochem J. 2004; 381(Pt 3):761-7. PMC: 1133886. DOI: 10.1042/BJ20040620. View

14.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

15.

Ciechanover A . The ubiquitin-proteasome proteolytic pathway. Cell. 1994; 79(1):13-21. DOI: 10.1016/0092-8674(94)90396-4. View

16.

Wang V, Davis D, Haque M, Huang L, Yarchoan R . Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res. 2005; 65(8):3299-306. DOI: 10.1158/0008-5472.CAN-04-4130. View

17.

Arquier N, Vigne P, Duplan E, Hsu T, Therond P, Frelin C . Analysis of the hypoxia-sensing pathway in Drosophila melanogaster. Biochem J. 2005; 393(Pt 2):471-80. PMC: 1360697. DOI: 10.1042/BJ20050675. View

18.

Jeong J, Bae M, Ahn M, Kim S, Sohn T, Bae M . Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation. Cell. 2002; 111(5):709-20. DOI: 10.1016/s0092-8674(02)01085-1. View

19.

Wong A, Yang J, Cavadini P, Gellera C, Lonnerdal B, Taroni F . The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum Mol Genet. 1999; 8(3):425-30. DOI: 10.1093/hmg/8.3.425. View

20.

Smith D, Kafri G, Cheng Y, Ng D, Walz T, Goldberg A . ATP binding to PAN or the 26S ATPases causes association with the 20S proteasome, gate opening, and translocation of unfolded proteins. Mol Cell. 2005; 20(5):687-98. DOI: 10.1016/j.molcel.2005.10.019. View